Skip to main content

Animations

MJFF Publications

5711 - 5720 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2020
  • 2019
  • 2019
  • 2020
  • 2020
  • 2013
  • 2003
  • Summary Details
    OPEN
    Title: Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008699
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.201
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/jnnp-2019-321794
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLs
    Journal Name: PLOS Genetics
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pgen.1008549
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00702-019-02125-6
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-019-02066-0
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-59414-4
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2020.00033
    Citation Count: 67
  • Summary Details
    OPEN
    Title: A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cell.2013.07.030
    Citation Count: 252
  • Summary Details
    OPEN
    Title: Pitx3 is required for development of substantia nigra dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0230529100
    Citation Count: 382
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.